Top Defensive Stocks To Watch Right Now

War. Tapering. Overly optimistic earnings forecasts. They all lurk in future. And yet…


The Dow Jones Industrials have gained 109 points, or 0.7%, to 14,942.66 at 12:21 today, on pace for their largest gain since August 1. The S&P 500, meanwhile, has risen 0.8% to 1,653.44, while the Nasdaq Composite has advanced 0.9% to 3,644.51.

Now, today could just be one day. It could be nothing more than a blip as markets head lower. But Morgan Stanley’s Adam Parker and team don’t think so. Parker lifted his 12-month price target on the S&P 500 to 1840 yesterday, despite his view that the market is too optimistic about corporate earnings. He just doesn’t care. Parker explains:

Since 1976, the median year-over-year growth forecast in January for the full year ahead is 14%, but expectations on average decline throughout the year to closer to the 5% average EPS growth we have seen over that period. Why? Analysts (and company managements) start the year optimistic and then adjust their optimism as the year progresses. Analysts often extrapolate or project incremental margin expectations that are excessively optimistic for many businesses. What’s our point? The market can work well even as the base case is being revised downward.

Top Defensive Stocks To Watch Right Now: Nordson Corporation(NDSN)

Nordson Corporation manufactures equipment used for precision dispensing, testing and inspection, and surface preparation and curing. Its Adhesive Dispensing Systems segment manufactures equipment for applying adhesives, lotions, and liquids to disposable products; automated adhesive dispensing systems for the food and beverage, and packaged goods industries; hot melt and cold glue adhesive dispensing systems for the paper and paperboard converting industries; adhesive and sealant dispensing systems for bonding or sealing plastic, metal, and wood products; and laminating and coating systems to manufacture continuous-roll goods in the nonwovens, textile, paper, and flexible-packaging industries. The company?s Advanced Technology Systems segment comprises automated gas plasma treatment systems used to clean and condition surfaces for the semiconductor, medical, and printed circuit board industries; controlled manual and automated systems for applying materials in customer pr ocesses requiring precision and material conservation; ultraviolet equipment used in curing and drying operations for specialty coatings, semiconductor materials, and paints; and bond testing and automated optical and x-ray inspection systems used in the semiconductor and printed circuit board industries. Its Industrial Coating Systems segment provides automated and manual dispensing systems used for applying coatings, paint, finishes, sealants, and other materials. Nordson Corporation markets its products in the United States and internationally through a direct sales force, as well as through qualified distributors and sales representatives. It serves various markets, including the appliance, automotive, bookbinding, container, converting, electronics, food and beverage, furniture, life sciences and medical, metal finishing, non woven, packaging, and semiconductor industries. The company was founded in 1935 and is headquartered in Westlake, Ohio.

Advisors’ Opinion:

  • [By Lauren Pollock]

    Nordson Corp.’s(NDSN) fiscal fourth-quarter earnings fell 12% on weaker demand, though the maker of dispensing equipment noted improvement in recent order trends.

  • [By Travis Hoium]

    What: Shares of industrial product manufacturer Nordson (NASDAQ: NDSN  ) dropped as much as 10% today after the company reported fiscal second-quarter earnings.

Top Defensive Stocks To Watch Right Now: Taiwan Semiconductor Manufacturing Co Ltd (TSM)

Taiwan Semiconductor Manufacturing Co., Ltd. is a Taiwan-based company principally engaged in the research, development, manufacture and distribution of integrated circuit (IC) related products. The Company operates its businesses through wafer manufacture, mask production, wafer testing and packaging components. The Company also involves in the provision of production management, customer services and design services. Its products and services are applied in the manufacture of personal computers and peripheral products, information related products, wire and wireless communication systems, automobile and industrial equipment, as well as consumer electronic products, such as digital disk players, digital televisions (TVs), game consoles, digital cameras, among others. Its customers include Altera, AMD, Broadcom, Marvell, NVIDIA, Qualcomm, Analog Devices, Freescale, NXP and Texas Instruments, among others. In July 2010, Taiwan Semiconductor Manufacturing Co. acquired mechan ical and engineering equipment from ASML HONG KONG LTD. In September 2010, the Company acquired a set of equipments from ASML HONG KONG LTD. In December 2010, the Company acquired a set of equipment from TOKYO ELECTRON LTD., KLA-TENCOR CORP. and NOVELLUS SYSTEMS INTERNATIONAL,B.V. In January 2011, the Company announced that it had acquired a set of equipment from KLA-TENCOR CORP., a set of equipment and facility, and another set of equipment from VARIAN SEMI. EQUIP. ASSOCIATES GmbH. In March 2011, the Company acquired a set of equipments from Rudolph Technologies, Inc.In March 2011, the Company acquired a set of equipments from Rudolph Technologies, Inc. In May 2011, it acquired a set of equipments form APPLIED MATERIALS SOUTH EAST ASIA PACIFIC LTD., Hamatech APE Gmbh and CO. KG, TOKYO ELECTRON LTD., DAINIPPON SCREEN MFG. CO., LTD., and VARIAN SEMI. EQUIP. ASSOCIATES GMBH.

TSMC’s customers include semiconductor companies, ranging from fabless semiconduct or and systems companies, such as Advanced Micro Devices, In! c., Altera Corporation, Broadcom Corporation, Marvell Semiconductor Inc., MediaTek Inc., nVidia Corporation and Qualcomm Incorporated, to integrated device manufacturers, such as LSI Corporation, STMicroelectronics and Texas Instruments Inc. Fabless semiconductor and system companies accounted for approximately 80%, and integrated device manufacturers accounted for approximately 20% of its net sales as of December 31, 2009.

The Company manufactures semiconductors using CMOS and BiCMOS processes. The BiCMOS process combines the speed of the bipolar circuitry and the power consumption and density of the CMOS circuitry. It uses the CMOS process to manufacture logic semiconductors, memory semiconductors, including static random access memory (SRAM), flash memory, mixed-signal/ radio frequency (RF) semiconductors, which combine analog and digital circuitry in a single semiconductor, micro-electro-mechanical-system (MEMS), which combines micrometer featured mechanical parts, analog and digital circuitry in a single semiconductor, and embedded memory semiconductors, which combine logic and memory in a single semiconductor. The BiCMOS process is used to make high-end mixed-signal and other types of semiconductors.

Advisors’ Opinion:

  • [By Ashraf Eassa]

    On the other hand, Taiwan Semiconductor (NYSE: TSM  ) and Samsung, the two remaining leading-edge foundries, are claiming that their 14/16-nanometer process technologies will be in high volume production during 2015. If we look at what has been announced so far in the way of products and timelines, we can get a sense of Intel’s competitive position:

  • [By Ashraf Eassa]

    Is the tide turning?
    According to Digitimes, chip manufacturer Taiwan Semiconductor (NYSE: TSM  ) , or TSMC, has apparently begun to see an uptick in orders from PC-levered names such as AMD (NYSE: AMD  ) and NVIDIA. (Intel builds its chips at its own manufacturing plants). While this is mildly positive for TSMC, which is also levered to the fast-growing mobile markets, it could end up being very positive for Intel and the PC-levered names in general.

Top Defensive Stocks To Watch Right Now: Shire PLC (SHPG)

Shire plc (Shire), incorporated on January 28, 2008, is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), gastrointestinal (GI) diseases, human genetic therapies (HGT) and regenerative medicine (RM), as well as opportunities in other therapeutic areas. As of December 31, 2012, the Company’s products included VYVANSE/VENVANSE (lisdexamfetamine dimesylate), ADDERALL XR (mixed salts of a single-entity amphetamine), INTUNIV (extended release guanfacine), EQUASYM (methylphenidate hydrochloride) modified release (XL), LIALDA (mesalamine)/ MEZAVANT(mesalazine), PENTASA (mesalamine), RESOLOR (prucalopride), FOSRENOL (lanthanum carbonate), XAGRID (anagrelide hydrochloride), REPLAGAL (agalsidase alfa), ELAPRASE (idursulfase), VPRIV (velaglucerase alfa), FIRAZYR (icatibant) and DERMAGRAFT(Human Fibroblast-Derived Dermal Substitute). As of December 31 , 2012, the Company’s products under development included INTUNIV (extended release guanfacine), VYVANSE/VENVANSE (lisdexamfetamine dimesylate), INTUNIV, Guanfacine Carrier Wave, LIALDA (mesalamine)/MEZAVANT (mesalazine), RESOLOR (prucalopride), RESOLOR (prucalopride), SPD 557(M0003), XAGRID, VYVANSE (lisdexamfetamine dimesylate), REPLAGAL (agalsidase alfa), HGT-4510, HGT-2310, HGT-1410, HGT-1110, HGT-3010, and DERMAGRAFT. On January 31, 2012, the United States Food and Drug Administration approved VYVANSE for the maintenance treatment of ADHD in adults. In March 2013, it announced the acquisition Of Premacure AB. In January 2014, Shire Plc sold its DERMAGRAFT assets to Organogenesis Inc. In January 2014, Shire Plc acquired 79.5% interest in ViroPharma Inc.


VYVANSE is a New Chemical Entity (NCE) and is the pro-drug stimulant for the treatment of ADHD, where the amino acid l-lysine is linked to d-amphetamine. VYVANSE is therapeutic ally inactive until metabolized in the body. The United Stat! es Food and Drug Administration approved VYVANSE as a once-daily treatment for children aged 6 to 12 with ADHD in February 2007, for adults in April 2008 and for adolescents aged 13 to 17 in November 2010. VYVANSE is available in the United States in six dosage strengths: 20 milligram, 30 milligram, 40 milligram, 50 milligram, 60 milligram and 70 milligram. Health Canada approved VYVANSE for the treatment of ADHD in pediatric patients aged 6 to 12 in February 2009, and for adolescents and adults in November 2010. In April 2012, ANVISA, the Brazilian health authority, granted marketing authorization approval for lisdexamfetamine dimesylate for the treatment of ADHD in children aged 6-12.


ADDERALL XR is an extended release treatment for ADHD, which uses MICROTROL drug delivery technology and is designed to provide once-daily dosing. It is available in 5 milligram, 10 milligram, 15 milligram, 20 milligram, 25 milligram and 30 milligram caps ules and can be administered either as a capsule or sprinkled on soft food. The United States Food and Drug Administration has approved ADDERALL XR as a once-daily treatment for children aged 6 to 12 with ADHD, for adults in and for adolescents aged 13 to 17. Teva Pharmaceutical Industries, Ltd. (Teva) and Impax Laboratories, Inc. (Impax) commenced commercial shipment of their authorized generic versions of ADDERALL XR in April and October 2009, respectively. Shire receives royalties from Impax’s sales of authorized generic ADDERALL XR.


INTUNIV is a selective alpha-2A receptor agonist indicated for the treatment of ADHD. Alpha-2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signalling in the prefrontal cortex (Cell. 2007; 129:397-410). INTUNIV is non-scheduled and has no known potential for abuse or dependence. The United States Food and Drug Administration approved INTUNIV in September 2009, as a once- daily monotherapy treatment of ADHD in children and adolesce! nts aged ! 6 to 17. It is available in 1 milligram, 2 milligram, 3 milligram and 4 milligram tablets.


Shire has acquired from UCB the worldwide rights (excluding the United States, Canada and Barbados) to EQUASYM (methylphenidate hydrochloride) IR and XL for the treatment of ADHD in children and adolescents aged 6 to 18. At December 31, 2012,EQUASYM XL was commercially available in 10 countries in 10mg, 20mg and 30mg strengths. EQUASYM XL is marketed in Mexico and South Korea under the trade name METADATE CD.


LIALDA is indicated for the induction ofmild to moderately active UC and for the maintenance of remission of UC. The addition of the indication for maintenance of remission of ulcerative colitis was approved by Health Canada in February 2011, and by the United States Food and Drug Administration in July 2011. LIALDA is once-daily oral formulation of mesalamine indicated for the induction and maintenance of remission. As of December 31, 2012, LIALDA/MEZAVANT (this product is marketed outside the United States as MEZAVANT) was commercially available in 19 countries either directly or through distributor arrangements.


PENTASA controlled release capsules are approved in the United States (marketed by Shire in the United States and by Ferring outside of the United States) and indicated for the induction of remission and for the treatment of patients with mild to moderately active ulcerative colitis. PENTASA is an ethylcellulose-coated, controlled release capsule formulation designed to release therapeutic quantities of mesalamine throughout the gastrointestinal tract. PENTASA is available in the United States in 250 milligram and 500 milligram capsules.


RESOLOR (prucalopride), a 5-HT4 receptor agonists that stimulates gastrointestinal motility and acts primarily on different parts of the lower gastrointesti nal tract (enterokinetic). In October 2009, RESOLOR was appr! oved by t! he EMA throughout the European Union as a once daily oral treatment for symptomatic treatment of chronic constipation in women in whom laxatives fail to provide adequate relief. In July 2010, Swissmedic granted RESOLOR marketing authorization in Switzerland for the treatment of idiopathic chronic constipation in adults. RESOLOR is available in milligram and 2 milligram dose strengths, both for once-daily dosing. At December 31, 2012, RESOLOR was available in six European Union countries. Formulated as a chewable tablet, FOSRENOL is available in 500 milligram, 750 milligram and 1,000 milligram dosage strengths.


XAGRID (anagrelide hydrochloride) is marketed in Europe for the reduction of elevated platelet counts in at-risk ET patients. XAGRID has been granted orphan drug status in the European Union. In the United States, anagrelide hydrochloride is sold by the Company under the name AGRYLIN for the treatment of thrombocythemia secondary to a MPD.


REPLAGAL is for the treatment of Fabry disease. Fabry disease is a genetic disorder resulting from a deficiency in the activity of the lysosomal enzyme alpha-galactosidase A, which is involved in the breakdown of fats. REPLAGAL is a human alpha-galactosidase A protein made in human cells that replaces the deficient alpha-galactosidase A with an active enzyme to ameliorate certain clinical manifestations of Fabry disease. At December 31, 2012, REPLAGAL was approved in 46 countries.


ELAPRASE is a treatment for Hunter syndrome (also known as Mucopolysaccharidosis Type II or MPS II). Hunter syndrome is a genetic disorder mainly affecting males that interferes with the body’s ability to break down and recycle waste substances called mucopolysaccharides, also known as glycosaminoglycans (GAGs). ELAPRASE was approved by the United States Food and Drug Administration and granted marketing authorization by the EMA for the long term treatment of patients with Hunter ! syndrome.! ELAPRASE has been granted orphan drug by both the United States Food and Drug Administration and the EMA. ELAPRASE received approval from the Ministry of Health, Labour and Welfare in Japan. At December 31, 2012, ELAPRASE was approved in 51 countries.


VPRIV is a treatment for Type 1 Gaucher disease. Gaucher disease is an inherited genetic disorder, which results in a deficiency of the lysosomal enzyme beta-glucocerebrosidase. VPRIV was approved by the United States Food and Drug Administration in February 2010, for the long-term treatment of patients with Type 1 Gaucher disease. The EMA approved the marketing authorization for the use of VPRIV in August 2010. VPRIV was authorized as an orphan medicine through the Centralised Procedure in Europe. At December 31, 2012, VPRIV was approved in 38 countries.


FIRAZYR is a peptide-based therapeutic developed for the symptomatic treatment of acute attacks of HAE. In July 2008 the EMA granted marketing authorization throughout the European Union for the use of FIRAZYR for the symptomatic treatment of acute attacks of HAE, and in May 2011 approved FIRAZYR for self-administration after training in subcutaneous injection technique by a healthcare professional. In August 2011, the United States Food and Drug Administration granted marketing approval for FIRAZYR in the United States for treatment of acute attacks of HAE in adults aged 18 and older. After injection training, patients may self-administer FIRAZYR. FIRAZYR has been granted orphan drug by both the United States Food and Drug Administration and the EMA. At December 31, 2012, FIRAZYR was approved in 38 countries globally.


DERMAGRAFT is a bio-engineered skin substitute that assists in restoring damaged tissue. DERMAGRAFT is indicated for use in the treatment of full-thickness Diabetic foot ulcers (DFU) greater than six weeks in duration, which extend through the dermis, but without tendon, muscle, joint capsu! le, or bo! ne exposure. DERMAGRAFT is approved by the United States Food and Drug Administration as a Class III medical device for the treatment of DFUs. DERMAGRAFT is also approved for the treatment of DFUs in South Africa, Israel and Singapore.

The Company competes with Shionogi & Co., Ltd., Janssen-Cilag, Novartis, Medice, Eli Lilly, Warner Chilcott, Synergy Pharmaceuticals, Inc., ARYx Therapeutics, Theravance, Inc., Sucampo Pharmaceuticals, Inc., Albireo, Actelion Ltd., Protalix BioTherapeutics Inc, Genzyme, CSL Behring, Pharming Group N.V., ViroPharma, Dyax Corporation, Organogenesis, Healthpoint, Soluble System, KCI, Smith & Nephew, Aurobindo and Apotex.

Advisors’ Opinion:

  • [By Ben Levisohn]

    Nevertheless, while we believe that the rejection vote is a setback to Valeant, we remain confident that Valeant will either ultimately succeed in its bid to acquire Allergan near-term or seek to consummate another transaction elsewhere. We note that thus far it does not appear that Allergan has much strategic wiggle room, having already been rebuffed by potential white knights such as Sanofi S.A. (SNY) and Johnson & Johnson (JNJ) and with little chance, in our view, of making a meaningful acquisition of its own, such as the purchase of Shire (SHPG).

  • [By Jesse Solomon]

    A flurry of acquisitions has already occurred in the past few years. Most recently, the Irish pharmaceutical conglomerate Shire (SHPG) bought Pennsylvania-based ViroPharma for $4.2 billion late last year. The deal gave Shire access to Cinryze, medicine for a rare blood disorder.

  • [By George Budwell]

    Shire plc (NASDAQ: SHPG  ) is in the process of buying orphan drug-specialist ViroPharma (NASDAQ: VPHM  ) for $4.2 billion, strengthening Shire’s already robust commercial drug portfolio for rare diseases. The deal is expected to be finalized no later than Jan. 9, after Shire extended its tender offer to acquire all outstanding ViroPharma shares last week.


    On Monday, Dublin-based pharmaceutical firm Shire (Nasdaq ADR: SHPG) announced that it will buy Pennsylvania-based ViroPharma (Nasdaq: VPHM) for $4.2 billion in cash. The $50 per share purchase price is a 27% premium to Viropharma’s Friday close and a 64% premium to the price when sale rumors first emerged this summer.

Top Defensive Stocks To Watch Right Now: Federal Realty Investment Trust (FRT)

Federal Realty Investment Trust (the Trust) is an equity real estate investment trust (REIT) specializing in the ownership, management, and redevelopment of retail and mixed-use properties located in metropolitan markets in the Northeast and Mid-Atlantic regions of the United States, as well as in California. As of December 31, 2011, the Trust owned or had interest in community and neighborhood shopping centers and mixed-use properties, which are operated as 87 retail real estate projects, consisting approximately 19.3 million square feet. On December 30, 2011, it acquired an 8.1 acre land parcel adjacent to Plaza El Segundo. In January 2012, the Company acquired 89.9% interest in Montrose Crossing. In January 2013, the Company acquired East Bay Bridge shopping center. In April 2013, it acquired a shopping center on 9 acres directly across from the Noroton Heights train station. In January 2014, Federal Realty Investment Trust acquired controlling interest in two shopping centers totaling 285,600 square feet in affluent Monmouth County, New Jersey.

The Company’s portfolio includes retail in many formats ranging from regional community and neighborhood shopping centers, which are anchored by grocery stores to mixed-use properties, which are centered around a retail component but also include office, residential and/or hotel components. During the year ended December 31, 2011, the Company signed leases for a total of 1,417,000 square feet of retail space, including 1,294,000 square feet of comparable space leases. As of December 31, 2011, the real estate projects were 93.4% leased and 92.4% occupied. As of December 31, 2011, it owned a 30% interest in seven retail real estate projects totaling approximately one million square feet. As of December 31, 2011, the Company owned 90.9% interest in joint venture properties, which were leased and occupied.

Advisors’ Opinion:

  • [By Dan Burrows]

    Heck, over the last 20 years, NNN stock generated an annual return of 12.3%. That beats the broader market by more than 3 percentage points, making this one of the top dividend stocks to ride out any roughness.

    Dependable Dividend Stocks: Federal Realty Investment Trust (FRT)

    Dividend Yield: 2.8%
    YTD Gain: 12%

  • [By Brad Thomas]

    REITs mentioned: (VTR), (OHI), (O), (DLR), (HCP), (HTA), (KIM), (FRT), (SPG), and (SKT).

    Note: This article is intended to provide information to interested parties. As I have no knowledge of individual investor circumstances, goals, and/or portfolio concentration or diversification, readers are expected to complete their own due diligence before purchasing any stocks mentioned or recommended.

  • [By Shauna O’Brien]

    Jefferies reported on Wednesday that it has upgraded real estate investment trust Federal Realty Investment Trust (FRT).

    The firm has raised its rating on FRT from “Hold” to “Buy,” and has increased the company’s price target from $112 to $116. This price target suggests a 13% upside from the stock’s current price of $100.75.

    Analyst Omotayo Okusanya noted: “Based on our recent tour of Assembly Row, we are now convinced about the long term value of this development project. Our recent management meetings on Sept 4th also indicate that: 1) development projects at Pike and Rose as well as Santana Row remain on track and 2) FRT remains on track to keep generating industry leading SS NOI growth. With FRT also well positioned for rising rates, we find the story compelling and upgrade the stock to Buy from Hold.”

    Looking ahead, the firm has cut its estimates for FY2013 from $4.64 to $4.62 per share. FY2014 estimates have also been lowered from $4.97 to $4.96 per share.

    Federal Realty Investment Trust shares were mostly flat during pre-market trading Wednesday. The stock has been mostly flat YTD.

Top Defensive Stocks To Watch Right Now: Great Lakes Dredge & Dock Corporation(GLDD)

Great Lakes Dredge & Dock Corporation engages in the business of marine construction, primarily dredging, and commercial and industrial demolition primarily in the east, west, and Gulf Coasts of the United States. The company?s Dredging segment is involved in capital dredging projects consisting of primarily port expansion projects, land reclamations, trench digging for pipelines, tunnels and cables, and other dredging related to the construction of breakwaters, jetties, and canals; beach nourishment projects, which involve moving sand from the ocean floor to shoreline locations; and maintenance dredging that includes the re-dredging of previously deepened waterways and harbors to remove silt, sand, and other accumulated sediments, as well as lake and river dredging, inland levee and construction dredging, environmental restoration, and habitat improvement. Its Demolition segment provides commercial and industrial demolition services. It is involved in exterior demolition that comprises dismantling and demolition of structures and foundations; and interior demolition, which includes removing specific structures within a building. This segment also engages in site development, removal of asbestos and other hazardous materials, and remediation of contaminated demolition materials. The company serves federal, state, and local governments; foreign governments; domestic and foreign private concerns, such as utilities and oil companies; general contractors; corporations that commission projects; nonprofit institutions, such as universities and hospitals; and local government and municipal agencies. It has a fleet of 33 dredges, including 8 deployed internationally; 19 material transportation barges; 2 drill boats; and various other specialized support vessels. The company was formerly known as Lydon & Drews Partnership and changed its name to Great Lakes Dredge & Dock Corporation in 1905. The company was founded in 1809 and is headquartered in Oak Brook, Illinois.

Advisors’ Opinion:

  • [By Seth Jayson]

    There’s no foolproof way to know the future for Great Lakes Dredge & Dock (Nasdaq: GLDD  ) or any other company. However, certain clues may help you see potential stumbles before they happen — and before your stock craters as a result.

  • [By Seth Jayson]

    When judging a company’s prospects, how quickly it turns cash outflows into cash inflows can be just as important as how much profit it’s booking in the accounting fantasy world we call “earnings.” This is one of the first metrics I check when I’m hunting for the market’s best stocks. Today, we’ll see how it applies to Great Lakes Dredge & Dock (Nasdaq: GLDD  ) .

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market’s best stocks, it’s worth checking up on your companies’ free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That’s what we do with this series. Today, we’re checking in on Great Lakes Dredge & Dock (Nasdaq: GLDD  ) , whose recent revenue and earnings are plotted below.

Top Defensive Stocks To Watch Right Now: SilverCrest Mines Inc (SVLC)

SilverCrest Mines Inc. (SilverCrest), incorporated on May 22, 1973, is engaged in the acquisition, exploration and development of mineral properties in Mexico and Central America. The Company’s principal focus is the development and operation of the Santa Elena Project, which property consists of seven mineral concessions totaling 2,726.54 hectares, portions of which include the producing Santa Elena gold and silver mine located northeast of Hermosillo, Sonora State, Mexico. It operates in three segments: the mine operations at Santa Elena, Mexico; mine exploration and evaluation projects at La Joya and Cruz de Mayo, Mexico, and Corporate. The Company is also focused on exploring and developing its La Joya Property located in Durango, Mexico, which contains a discovered polymetallic deposit. The Company’s other mineral properties include the Cruz de Mayo Project (Mexico), the La Joya Property (Mexico), the Silver Angel Project (Mexico) and the El Zapote Project (El Sal vador).

The La Joya Property consists of 14 mineral concessions with a total area of approximately 8,379.6 hectares. Its Cruz de Mayo Project consists of two mineral concessions comprising a total of 452 hectares. The Company holds a 100% interest in the Cruz de Mayo 2 concession (which encompasses 434 hectares). The Silver Angel Project consists of two mineral concessions encompassing a total of 3,251 hectares located in the northern Sierra Madre Range in Sonora, Mexico. The Company holds a 100% interest in these concessions, which were acquired by concession applications.

The El Zapote Project consists of two mineral concessions (the El Caliche and San Juan Exploration Concessions) located in the Department of Santa Ana in northern El Salvador, Central America. The Company holds a 100% interest in the El Zapote Project. During the year ended December 31, 2011, an initial drill program of 25 holes totaling approximately 2,900 meters was completed o n the Santa Elena Norte target, located approximately 1 kilo! meters north of the Santa Elena Mine.

Advisors’ Opinion:

  • [By Hebba Investments]

    Even with rising Q2 costs, GG still has lower true all-in costs than many of its larger competitors’ Q1FY13 costs. Compared to Q1FY13 numbers of competitors such as Yamana Gold (AUY) (costs just over $1300), Kinross Gold (KGC) (costs above $1350), Silvercrest Mines (SVLC) (costs below $1100), Newmont Gold (NEM) (costs around $1300) Agnico-Eagle (AEM) (costs around $1400) and Barrick Gold (ABX) (costs around $1200).

Top Defensive Stocks To Watch Right Now: Extreme Networks Inc.(EXTR)

Extreme Networks, Inc., together with its subsidiaries, develops and markets network infrastructure equipment and services to businesses, hospitals, schools, hotels, telecommunications companies, and government agencies. It offers Summit product family of stackable Ethernet switching systems that provide 10 megabit to 40 gigabit connection speeds, various physical presentations, and options to deliver power-over-Ethernet or unpowered standard Ethernet ports; and Black Diamond family of modular Ethernet switching systems, which deliver modular or chassis-based Ethernet connectivity solutions for enterprises, data centers, and service providers. The company also offers SummitWM family of wireless network controllers and associated Altitude access points to enable the deployment of nomadic and mobile converged network applications; and RidgeLine management software system that includes features tailored to data center, campus, and service provider management. It has strategic relationships with Motorola Inc., Netgear, Inc., Ericsson Enterprise AB, and Nokia Siemens Networks. The company sells its products through distributors, resellers, and field sales organizations. It operates in the United States, Canada, Mexico, Japan, Central America, Europe, the Middle East, Africa, South America, and the Asia Pacific. Extreme Networks, Inc. was founded in 1996 and is headquartered in Santa Clara, California.

Advisors’ Opinion:

  • [By Jake L’Ecuyer]

    Extreme Networks (NASDAQ: EXTR) shares tumbled 15.38 percent to $5.96 after the company reported downbeat Q2 results and issued a weak Q3 profit forecast.

  • [By Jake L’Ecuyer]

    Extreme Networks (NASDAQ: EXTR) shares tumbled 17.33 percent to $5.82 after the company reported downbeat Q2 results and issued a weak Q3 profit forecast.

  • [By Rich Bieglmeier]

    We like to take it one step further than just buying, iStock specifically targets insiders with a history of making the correct call. Extreme Networks Inc. (EXTR) Director, Maury Austin is taking a second bite of the apple.

Top Defensive Stocks To Watch Right Now: Golub Capital BDC Inc (GBDC)

Golub Capital BDC, Inc. (Golub Capital BDC), incorporated on November 9, 2009, is an externally managed, closed-end, non-diversified management investment company. The Company’s investment objective is to generate current income and capital appreciation by investing primarily in senior secured, one stop, second lien, subordinated loans of, and warrants and minority equity securities in, United States middle market companies. The Company seeks to create a diverse portfolio that includes senior secured, one stop, second lien and subordinated loans and warrants and minority equity securities by primarily investing in the securities of United States middle market companies. The Company’s investment activities are managed by the Company’s investment adviser, GC Advisors LLC (GC Advisors).

The Company seeks to generate risk-adjusted net returns by assembling a diversified portfolio of investments across a broad range of industries and private equity investors. The C ompany seeks to create a diverse portfolio that includes senior secured, one stop, second lien and subordinated loans and warrants and minority equity securities by primarily investing on average, in the securities of United States middle market companies. The Company primarily targets United States middle markets companies controlled by private equity investors that require capital for growth, acquisitions, recapitalizations, refinancings and leveraged buyouts. The Company may also make opportunistic loans to independently owned and publicly held middle market companies. The Company focuses on senior secured loans and one stops investments, given the principal protection from the first lien security interest associated with such loans.

Senior Secured Loans

The Company structures these investments as senior secured loans. The Company obtains security interests in the assets of the portfolio company that serve as collateral in support of the r epayment of such loans. This collateral may take the form of! first-priority liens on the assets of the portfolio company borrower. The Company’s senior secured loans may provide for moderate loan amortization in the early years of the loan, with the majority of the amortization deferred until loan maturity.

One Stop Loans

The Company structures its one stop loans as senior secured loans. The Company obtains security interests in the assets of the portfolio company that serve as collateral in support of the repayment of these loans. This collateral may take the form of first-priority liens on the assets of the portfolio company. One stop loans typically provide for moderate loan amortization in the initial years of the facility, with the majority of the amortization deferred until loan maturity. One stop loans generally allow the borrower to make a lump sum payment of principal at the end of the loan term, and there is a risk of loss if the borrower is unable to pay the lump sum or refinance the amount owed a t maturity.

Second Lien Loans

The Company structures these investments as junior, secured loans. The Company obtains security interests in the assets of the portfolio company that serve as collateral in support of the repayment of such loans. This collateral may take the form of second priority liens on the assets of a portfolio company. Second lien loans typically provide for moderate loan amortization in the initial years of the facility, with the majority of the amortization deferred until loan maturity.

Subordinated Loans

1The Company structures these investments as unsecured, subordinated loans that provide for relatively high, fixed interests rates that provide the Company with interest income. These loans typically have interest-only payments (often representing a combination of cash pay and payment-in-kind, or PIK, interest) with amortization of principal deferred until loan maturity.

Advisors’ Opinion:

  • [By Monica Gerson]

    Golub Capital BDC (NASDAQ: GBDC) dipped 2.88% to $17.89 in pre-market trading after the company announced a public offering of 3.5 million shares of its common stock.

  • [By GuruFocus]

    SVP and CFO Michael D James bought 2,500 shares of GMAN stock on 12/17/2013 at the average price of 7.1. Michael D James owns at least 69,158 shares after this. The price of the stock has increased by 6.9% since.

    Golub Capital BDC, Inc. (GBDC): CEO, 10% Owner David Golub Bought 5,000 Shares

    CEO, 10% Owner of Golub Capital BDC, Inc. (GBDC) David Golub bought 5,000 shares on 12/23/2013 at an average price of $18.71. Golub Capital BDC, Inc. was formed in November 2009. Golub Capital Bdc, Inc. has a market cap of $810.256 million; its shares were traded at around $18.71 with a P/E ratio of 13.90 and P/S ratio of 7.70. The dividend yield of Golub Capital Bdc, Inc. stocks is 6.84%.

Top Defensive Stocks To Watch Right Now: PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund (STPZ)

PIMCO 1-5 Year US TIPS Index ETF, formerly Pimco 1-5 Year U.S. TIPS Index Fund, is an exchange traded fund (ETF) designed to capture the returns of the shorter maturity subset of the Treasury Inflation-Protected Securities (TIPS) market by tracking The BofA Merrill Lynch 1-5 Year US Inflation-Linked Treasury Index. The BofA Merrill Lynch 1-5 Year US Inflation-Linked Treasury Index is an unmanaged index comprised of the United States Treasury Inflation Protected Securities with at least $1 billion in outstanding face value and a remaining term to final maturity of at least one year and less than five years. Advisors’ Opinion:

  • [By Benjamin Shepherd]

    While there are several exchange-traded funds (ETFs) devoted to TIPS, my favorite is PIMCO 1-5 Year US TIPS Index (NYSE: STPZ).

    This ETF has one of the lowest durations of any of the TIPS funds at 2.7 years, so it won’t take much of a ding based on shifting interest rates.

Top Defensive Stocks To Watch Right Now: Northern Trust Corporation(NTRS)

Northern Trust Corporation, through its subsidiaries, provides asset servicing, fund administration, asset management, and fiduciary and banking solutions for corporations, institutions, families, and individuals worldwide. The company offers corporate and institutional services, including global master trust and custody, trade settlement, and reporting; fund administration; cash management; investment risk and performance analytical services; investment operations outsourcing; and transition management and commission recapture services. It also provides personal financial services, such as personal trust, investment management, custody, and philanthropic services; financial consulting; guardianship and estate administration; brokerage services; and private and business banking services, as well as customized products and services. In addition, the company offers active and passive equity and fixed income portfolio management, as well as alternative asset classes comprisin g private equity and hedge funds of funds, and multi-manager products and advisory services. Further, it engages in fund administration, investment operations outsourcing, and custody business that provides specialized services to a range of funds, which include money-market, multi-manager, exchange-traded funds, and property funds for on-shore and off-shore markets. Additionally, the company provides administrative and middle-office services consisting of trade processing, valuation, real-time reporting, accounting, collateral management, and investor servicing. Northern Trust Corporation was founded in 1889 and is based in Chicago, Illinois.

Advisors’ Opinion:

  • [By John Kell and Lauren Pollock var popups = dojo.query(“.socialByline .popC”); ]

    Northern Trust Corp.(NTRS) said its first-quarter earnings rose 11% as the trust bank reported higher net interest income and trust, investment and other servicing fees. But results missed the estimates of analysts polled by Thomson Reuters.

  • [By E.S. Browning]

    This view is spreading. When Northern Trust(NTRS) surveyed 100 outside investment managers at the end of last year, 34% called themselves more risk averse, up from 20% in the third quarter. Only 36% said U.S. stocks are undervalued.

  • [By Selena Maranjian]

    Northern Trust (NASDAQ: NTRS  )

    To earn their high scores, the companies above engaged in a variety of good practices, including applying their human rights policy to their suppliers and vendors, and committing to quantifiable targets and goals.

  • [By Holly LaFon]

    In the fourth quarter, Yacktman’s biggest additions to his holdings were Research In Motion (RIMM) and Avon Products (AVP). He also surprised followers by venturing into financials, with new positions in Goldman Sachs (GS), Bank of America (BAC), State Street Corp. (STT) and Northern Trust Corp. (NTRS).